Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

211 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators, Marth C. Gnant M, et al. N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285. N Engl J Med. 2009. PMID: 19213681 Clinical Trial.
Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results).
Samonigg H, Stöger H, Bauernhofer T, Schmid M, Kasparek AK, Kuss I, Kaul M, Heberle U, Vieder L, Dusleag J, et al. Samonigg H, et al. Am J Clin Oncol. 1990;13 Suppl 1:S44-7. Am J Clin Oncol. 1990. PMID: 2291457 Clinical Trial.
4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
Samonigg H, Kasparek AK, Stöger H, Schmid M, Eber B, Stark G, Weinrauch V, Pfeiffer K, Smola M, Steindorfer P, et al. Samonigg H, et al. Cancer Chemother Pharmacol. 1990;26(4):293-6. doi: 10.1007/BF02897233. Cancer Chemother Pharmacol. 1990. PMID: 2369794
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.
Hausmaninger H, Lehnert M, Steger G, Sevelda P, Michlmayr G, Hehenwarter W, Fridrik M, Samonigg H, Schiller L, Manfreda D, et al. Hausmaninger H, et al. Onkologie. 1989 Oct;12(5):225-9. doi: 10.1159/000216651. Onkologie. 1989. PMID: 2685688 Clinical Trial.
Aclarubicin in advanced thyroid cancer: a phase II study.
Samonigg H, Hossfeld DK, Spehn J, Fill H, Leb G. Samonigg H, et al. Eur J Cancer Clin Oncol. 1988 Aug;24(8):1271-5. doi: 10.1016/0277-5379(88)90214-3. Eur J Cancer Clin Oncol. 1988. PMID: 3181249
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Stöger H, Bauernhofer T, Schmid M, Ploner F, Moser R, Derstvenscheg E, Steindorfer P, Wilders-Truschnig M, Kuss I, Samonigg H. Stöger H, et al. Cancer Chemother Pharmacol. 1994;35(2):174-8. doi: 10.1007/BF00686643. Cancer Chemother Pharmacol. 1994. PMID: 7987997 Clinical Trial.
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E. Ludwig H, et al. Cancer. 1995 Dec 1;76(11):2319-29. doi: 10.1002/1097-0142(19951201)76:11<2319::aid-cncr2820761121>3.0.co;2-u. Cancer. 1995. PMID: 8635038 Clinical Trial.
211 results
Jump to page
Feedback